## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the abstract, without access to full text, figures, or supplementary materials
- **Shared manuscript claim summary** The authors propose a "secondary conformational checkpoint" in CRISPR-Cas9 that operates between target DNA binding and cleavage. Using submillisecond molecular dynamics simulations, they report that base mismatches alter the functional modes of the HNH nuclease domain, impairing conformational activation. They further claim that evoCas9, an evolved high-fidelity variant, deviates from the normal activation pathway under mismatch conditions, with shifted HNH positioning and perturbed allosteric communication, and that this reinforces the secondary checkpoint in addition to a previously identified primary checkpoint. They generalize this mechanism to other high-fidelity Cas9 guide RNA variants.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or simulation details provided
- **Missing materials affecting confidence** Full manuscript, simulation protocols, force field parameters, system setup, convergence criteria, statistical analyses, structural figures, and any quantitative metrics supporting the claims

## Reviewer
- **Overall assessment** The abstract presents an intriguing hypothesis regarding a secondary conformational checkpoint in Cas9 fidelity, supported by molecular dynamics simulations. However, the evidence base is limited to a summary, and the claims are broad relative to the visible data. The mechanistic interpretation is plausible but requires rigorous validation of simulation quality, statistical robustness, and functional relevance. The generalization to other Cas9 variants is currently speculative.
- **Who would be interested in the results, and why** Researchers in CRISPR biology, gene editing technology development, and computational biophysics would find this relevant. Those engineering high-fidelity Cas9 variants or studying conformational dynamics of multidomain enzymes would benefit from the proposed checkpoint concept, as it may inform rational design of improved editing tools.
- **Major strengths** The hypothesis of a secondary conformational checkpoint is conceptually novel and extends existing models of Cas9 fidelity. The focus on late-stage transitions from the precleavage state addresses a less explored regime. The use of an evolved variant (evoCas9) as a comparative system is a sound approach to dissect mechanistic determinants.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  Originality: The secondary checkpoint concept is a fresh contribution, though it builds on prior work on Cas9 conformational control.  
  Scientific importance: Potentially high for gene editing fidelity, but the impact depends on experimental validation.  
  Interdisciplinary readership: Appeals to computational chemists, structural biologists, and CRISPR engineers, but the abstract may be too specialized for a broad audience.  
  Technical soundness: Cannot be fully assessed from the abstract; simulation quality and statistical rigor are unverified.  
  Readability for nonspecialists: The abstract is dense and assumes familiarity with Cas9 domain nomenclature and MD simulation concepts, limiting accessibility.
- **Recommendation posture** Currently not established from the provided evidence. Supportive if technical concerns are resolved and full data confirm the claims.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The claim that "submilliseconds of dynamic simulations reveal that the presence of base mismatches leads the HNH nuclease domain of Cas9 to alter its principal functional modes of motion"  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The abstract provides no details on simulation length, number of replicates, force field, system size, or convergence criteria. Submillisecond timescales are mentioned, but it is unclear whether the simulations reached equilibrium or sampled sufficient conformational space to support claims about "principal functional modes of motion."  
- **Why it matters** Without evidence of sampling convergence and statistical robustness, the observed changes in HNH dynamics could be artifacts of insufficient sampling or initial conditions, undermining the central mechanistic conclusion.  
- **Resolution test** Provide convergence metrics (e.g., RMSD stability, principal component analysis eigenvalue convergence), replicate simulations, and error bars for the reported mode changes. Show that the mismatch-induced alterations are reproducible and statistically significant.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The claim that "evoCas9 is prone to deviating from the normal activation pathway with base mismatches" and that this is "characterized by a noticeable shift in the positioning of the HNH domain and a significantly perturbed allosteric communication network"  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The abstract does not define what constitutes a "normal activation pathway" or how deviation is quantified. The "noticeable shift" and "significantly perturbed" allosteric network lack quantitative thresholds or statistical tests. No comparison to wild-type Cas9 under matched conditions is described.  
- **Why it matters** The comparative claim between evoCas9 and wild-type Cas9 is central to the paper's conclusion. Without clear metrics and statistical validation, the observed differences could be within noise or due to different simulation setups.  
- **Resolution test** Define quantitative order parameters for HNH positioning and allosteric communication (e.g., residue-residue correlation differences). Provide statistical comparisons (e.g., bootstrapping or permutation tests) between wild-type and evoCas9 under identical mismatch conditions.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Scientific importance  
- **Claim pointer** The claim that "this mechanism should also apply to other Cas9-guide RNA variants with enhanced fidelity"  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** This generalization is made without any data on other variants. The abstract only studies Cas9 and evoCas9, and the mechanistic basis for extending the conclusion to all high-fidelity variants is not established.  
- **Why it matters** Overgeneralization could mislead the field into assuming a universal mechanism without evidence, potentially affecting future engineering efforts.  
- **Resolution test** Either remove the generalization or provide supporting simulations or experimental data on at least one additional high-fidelity variant (e.g., SpCas9-HF1 or eSpCas9) to demonstrate transferability.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** No  
- **Axis** Scientific importance  
- **Claim pointer** The claim that the secondary checkpoint "fine-tunes the final DNA cleavage activation" and that evoCas9 mutations "reinforce the secondary checkpoint in addition to the previously identified primary checkpoint"  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The functional significance of the proposed secondary checkpoint is inferred from simulations alone. No experimental validation (e.g., cleavage assays with mutant HNH variants or altered allosteric residues) is presented to confirm that the observed conformational changes directly affect cleavage activity.  
- **Why it matters** The paper's impact depends on linking conformational dynamics to function. Without experimental correlation, the checkpoint remains a computational hypothesis.  
- **Resolution test** Provide experimental data (e.g., in vitro cleavage assays with designed mutations that disrupt the proposed checkpoint) or cite existing experimental evidence that directly supports the functional role of the identified conformational states.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Readability  
- **Affected element** Abstract text  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The term "secondary conformational checkpoint" is introduced without a clear definition or contrast to the "primary checkpoint," which may confuse readers unfamiliar with prior work.  
- **Required correction** Briefly define both checkpoints in the abstract or refer explicitly to prior literature for the primary checkpoint.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Technical soundness  
- **Affected element** Simulation description  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The phrase "submilliseconds of dynamic simulations" is vague; it does not specify whether this refers to aggregate or per-replicate timescales.  
- **Required correction** Specify the total simulation time per system and the number of replicates in the abstract or methods.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Readability  
- **Affected element** Abstract text  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The term "principal functional modes of motion" is used without explaining how these modes are derived or what makes them "functional."  
- **Required correction** Clarify the method (e.g., principal component analysis) and define "functional" in terms of relevance to catalytic activation.

## Risk / unsupported claims
- The generalization to other high-fidelity Cas9 variants is unsupported by the visible evidence.
- The functional significance of the secondary checkpoint is not directly validated by experimental data.
- The quantitative basis for "noticeable shift" and "significantly perturbed" allosteric communication is not provided.
- The claim that base mismatches "impair conformational activation" is inferred from simulation dynamics without experimental correlation.